Apexigen, Inc. Rings the Nasdaq Stock Market Closing Bell
Apexigen, Inc. (Nasdaq: APGN), a company whose mission is to discover and develop innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Xiaodong Yang, President and CEO, rings the Closing Bell.